Bio

Professor Etyang underwent his undergraduate and postgraduate medical education at the University of Nairobi in Kenya. He joined KWTRP in 2010 to set up ward based surveillance for invasive pneumococcal disease at the Kilifi County Hospital. He subsequently did an MSc and PhD in Epidemiology at the London School of Hygiene and Tropical Medicine, exploring potential links between infectious and non-communicable diseases. Professor Etyang’s studies are providing much needed local data for control of high burden infectious and non-communicable diseases. His work spans a wide range of study designs and settings, including clinic and field based observational studies as well as clinical trials in Kenya and other low and middle income countries.

See more

Current Work

Prof. Etyang is the current head of the Department of Epidemiology and Demography. His main areas of interest are: • Hypertension: accuracy of blood pressure measurement; risk stratification for cardiovascular disease; links between malaria and hypertension; IHCoR Africa-Improving Hypertension Control in Rural sub-Saharan Africa • Clinical Trials- REALITY (Reduction of Early Mortality in HIV-infected adults and children starting antiretroviral therapy); SONIA (Steroids for pneuomonia in adults in Kenya); COPCOV (Hydroxychloroquine for prevention of COVID-19); COVID-19 vaccine trials • Serosurveillance for antibodies to SARS-CoV-2 in Health Care Workers in Kenya and COVID-19 effectiveness studies Other Roles; Advisory/technical working groups; Kilifi NCD Working Group, Lancet Commission on Hypertension, NIHR SPARC awards selection committee Reviewer roles: Lancet Global Health, Eclinical Medicine, Heart, European Heart Journal, F1000, PLOS, European Journal of Preventive Cardiology

See more

Recent publications

Determining the optimal diagnostic and risk stratification approaches for people with hypertension in two rural populations in Kenya and The Gambia: a study protocol for IHCoR-Africa Work Package 2.
Perkins, A. D., Awori, J. O., Jobe, M., Lucinde, R. K., Siemonsma, M., Oyando, R., Leon, D. A., Herrett, E., Prentice, A. M., Shah, A. S., Perel, P., Etyang, A.
NIHR Open Res, (2023). 3:68

Evaluating the implementation of the Primary Health Integrated Care Project for Chronic Conditions: a cohort study from Kenya.
Mugo, R., Pliakas, T., Kamano, J., Sanga, L. A., Nolte, E., Gasparrini, A., Barasa, E., Etyang, A., Perel, P.
BMJ Public Health, (2024). 2:e000146

STRIKE-HBV: establishing an HBV screening programme in Kilifi, Kenya-challenges, successes and lessons learnt.
Downs, L. O., Chirro, O., Zaharani, M., Safari, B., Okanda, D., Githinji, G., Andersson, M. I., Newton, R., Etyang, A., Aliyan, N., Matthews, P. C.
Sex Transm Infect, (2024). 100:325-328

Safety and immunogenicity of ChAdOx1 nCoV-19 (AZD1222) vaccine in adults in Kenya: a phase 1/2 single-blind, randomised controlled trial.
Hamaluba, M., Sang, S., Orindi, B., Njau, I., Karanja, H., Kamau, N., Gitonga, J. N., Mugo, D., Wright, D., Nyagwange, J., Kutima, B., Omuoyo, D., Mwatasa, M., Ngetsa, C., Agoti, C., Cheruiyot, S., Nyaguara, A., Munene, M., Mturi, N., Oloo, E., Ochola-Oyier, L., Mumba, N., Mauncho, C., Namayi, R., Davies, A., Tsofa, B., Nduati, E. W., Aliyan, N., Kasera, K., Etyang, A., Boyd, A., Hill, A., Gilbert, S., Douglas, A., Pollard, A., Bejon, P., Lambe, T., Warimwe, G.
Wellcome Open Res, (2023). 8:182

Where do those data go? Reuse of screening results from clinical trials to estimate population prevalence of HBV infection in adults in Kilifi, Kenya.
Downs, L. O., Campbell, C., Abouyannis, M., Otiende, M., Kapulu, M., Obiero, C. W., Hamaluba, M., Ngetsa, C., Andersson, M. I., Githinji, G., Warimwe, G., Baisley, K., Scott, J. A. G., Matthews, P. C., Etyang, A.
J Virus Erad, (2023). 9:100355